Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05968157

MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University of Massachusetts, Worcester · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Not accepted

Summary

Accurate risk assessment is essential for the success of population screening programs and early detection efforts in breast cancer. Mirai is a new deep learning model based on full resolution mammograms. Mirai is a mammography-based deep learning model designed to predict risk at multiple timepoints, leverage potentially missing risk factor information, and produce predictions that are consistent across mammography machines. Mirai was trained on a large dataset from Massachusetts General Hospital (MGH) in the United States and found to be significantly more accurate than the Tyrer-Cuzick model, a current clinical standard. The primary aim of this study is to prospectively quantify the clinical benefit (i.e. MRI/CEM cancer detection rate) of Mirai-based guidelines and to compare them to the current standard of care. 1. Conduct a prospective study where patients who are identified as high risk by Mirai guidelines are invited to receive supplemental MRI within 12 months. 2. Compare cancer outcomes between patients only identified as high risk by Mirai and patients identified as high risk by existing guidelines The secondary aim is to study the impact of new guidelines by race and ethnicity, to ensure equitable improvements in cancer screening.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBreast MRISupplemental MRI (in addition to standard of care MRI).
DEVICEMIRAIArtificial intelligence software

Timeline

Start date
2024-02-04
Primary completion
2026-06-01
Completion
2027-09-01
First posted
2023-08-01
Last updated
2026-01-07

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05968157. Inclusion in this directory is not an endorsement.